Dr. Carlos Galvez, MD

  • Chicago, IL
  • Hematologist and oncologist
NPI1407219462PAC ID4688919293
Medicare services, 2024
262
Medicare patients, 2024
74
Part D claims, 2024
190
Publications
15
MIPS score, 2024
95
Practice address
1740 West Taylor St Suite 1400, Chicago, IL 60612
Practice phone
Call (312) 996-3900
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

University of Illinois Hospital

Hospital · Chicago, Illinois

See all 6 affiliations

Find Dr. Galvez's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Carlos Galvez is a hematologist and oncologist in Chicago, Illinois

Dr. Galvez practices at University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System.

Dr. Galvez's NPI, 1407219462, was assigned on March 29, 2016. Dr. Galvez graduated from University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) in 2016. Dr. Galvez holds Illinois license 036149745.

NPI and contact details
Medicare PAC ID
4688919293
NPI enumeration date
March 29, 2016
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(312) 996-3900
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
36
Medical school graduation
2016

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Carlos Galvez practices at University of Illinois Hospital in Chicago, Illinois

Dr. Galvez's primary practice is University of Illinois Hospital, at 1740 West Taylor St Suite 1400, Chicago, IL 60612 in Cook County. The practice phone is (312) 996-3900.

Source: Dmand AI Affiliation Data

Dr. Carlos Galvez is affiliated with 4 sites of care and 2 medical groups

Dr. Galvez's primary practice is University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System. Dr. Galvez is also affiliated with John H. Stroger, Jr. Hospital of Cook County. The medical group on file is University of Illinois Physicians Group (UIPG). Dmand AI also links Dr. Galvez to 2 more group practices and clinics and 1 medical group, each named with a free account.

See all 6 affiliations for Dr. Galvez

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Carlos Galvez's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Galvez practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
University of Illinois HospitalAvailable with a free account
+3 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Galvez practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Illinois System and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Carlos Galvez is one of 563 hematologists and oncologists in Illinois

Hematology and oncology is Dr. Galvez's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Galvez is licensed in Illinois.

Specialties and state licenses

  • Hematology and oncology, IllinoisPrimaryLicense 036149745 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Galvez

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Carlos Galvez billed Medicare for 262 services in 2024

CMS data shows 262 Medicare services from Dr. Galvez across 4 procedure codes in 2024, for 74 Medicare patients. Medicare paid $21,629 for them.

Medicare services, 2024262
Medicare patients74
Paid by Medicare$21,629
Procedure codes4

Dr. Galvez's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 2262024: 18419%
Other services
2023: 02024: 78

Where Dr. Galvez's Medicare services took place, 2024

  • In an office2510%
  • In a facility23790%

Dr. Galvez compared with the Illinois median for hematologists and oncologists, 2024

  • Dr. Galvez
  • Illinois median
Medicare services
262vs 1,05675% below
Medicare patients
74vs 28274% below
Part D claims
85vs 32874% below

Medians across 547 hematologists and oncologists in Illinois with Dmand AI profiles that report each measure.

Dr. Galvez's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Galvez

Need commercial claims for Dr. Galvez?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Galvez and other hematologists and oncologists in Illinois.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Carlos Galvez treated 74 Medicare patients in 2024, average age 67

CMS counts 74 Medicare patients who saw Dr. Galvez in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 55% have high cholesterol. 61% are also on Medicaid. Their average risk score is 3.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Galvez's median patient age at 67, with 48% women.

Medicare patients, 202474
Average age67
Average risk score3.02
Also on Medicaid61%

Dr. Galvez's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Galvez's Medicare patients by sex, 2024

  • Women3547%
  • Men3953%

Chronic conditions among Dr. Galvez's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol55%
  3. Arthritis41%
  4. Diabetes35%
  5. Heart failure35%
  6. Chronic kidney disease32%
  7. Mood disorders31%
  8. COPD30%

Share of Medicare patients with each condition. A patient can have several.

Dr. Galvez's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 67

Patient panel by sex, all payers

  • Women48%
  • Men52%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Carlos Galvez wrote 190 Medicare Part D claims in 2024

In 2024, Dr. Galvez wrote 190 Medicare Part D claims for 28 patients. 76% of them were for generic drugs. CMS names the drug for 85 of them, across 5 drugs with 11 or more claims each, at $453,751 in total drug cost. In 2023, CMS named 88 claims across 5 drugs.

Part D claims, 2024190
Drugs named by CMS5
Total drug cost$453,751
Part D patients28

Dr. Galvez's Part D claims by kind of drug, 2024

  • Generic144 claims76%
  • Brand-name46 claims24%

Dr. Galvez's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Galvez's Part D claims, 2024

  • Antibiotics12%22 of 190 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 882024: 853%

Drugs named by CMS: 5 in 2024, 5 in 2023.

See all prescribing by Dr. Galvez

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Carlos Galvez scored 95 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Galvez for performance year 2024, reported as part of a group. Dr. Galvez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Galvez as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Galvez's MIPS scores, performance year 2024

  • 95of 100Final score
  • 74.7of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 85of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Galvez by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Carlos Galvez has 15 publications on record

Dmand AI links 15 papers to Dr. Galvez, published from 2017 to 2025. 2024 was the busiest year, with 3. Dr. Galvez has published most often in Blood Adv. Dr. Galvez's most frequent co-authors are Leo I. Gordon, MD, Reem Md Karmali, MD and Jane N. Winter, MD.

Papers15
Years published2017 to 2025

Dr. Galvez's papers by year, 2017 to 2025

Dr. Galvez's most frequent co-authors

Recent publications by Dr. Galvez

See all 15 publications and co-authors

See who Dr. Galvez researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Galvez works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Carlos Galvez received $11,679 in industry payments from 2023 to 2025

CMS Open Payments shows 21 general payments to Dr. Galvez from 7 drug and device companies from 2023 to 2025. Consulting fees make up the largest share, 84% of the total. Kite Pharma, Inc. paid the most, $8,922.

General payments to Dr. Galvez by program year, 2023 to 2025

General payments to Dr. Galvez by kind, 2023 to 2025

$11.7Kin total
  • Consulting fees$9,86584%
  • Food and beverage$8427%
  • Travel and lodging$8417%
  • Education$1311%

Companies that paid Dr. Galvez the most, 2023 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Galvez

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Carlos Galvez graduated from University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb)

Dr. Galvez graduated from University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) in 2016.

  1. Medical schoolUniversity of Illinois College of Med (Chi/Peor/Rock/Chm-Urb)

Source: Dmand AI Professional Profile Data

Sources for Dr. Carlos Galvez's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Carlos Galvez

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Carlos Galvez's NPI number?

Dr. Carlos Galvez's NPI number is 1407219462. It was assigned on March 29, 2016, and it is active in the NPI Registry.

What kind of doctor is Dr. Carlos Galvez?

Dr. Carlos Galvez is a hematologist and oncologist in Chicago, Illinois. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Carlos Galvez practice?

Dr. Galvez practices at 1740 West Taylor St Suite 1400, Chicago, IL 60612. Dr. Galvez's primary practice is University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System. Dmand AI also links Dr. Galvez to 2 group practices and clinics and 1 medical group.

What is Dr. Carlos Galvez's office phone number?

The practice phone on file for Dr. Galvez is (312) 996-3900.

What is Dr. Carlos Galvez's medical license number?

Dr. Galvez holds Illinois license 036149745.

Which hospitals is Dr. Carlos Galvez affiliated with?

Dr. Galvez practices at University of Illinois Hospital in Chicago, Illinois. Dr. Galvez is also affiliated with John H. Stroger, Jr. Hospital of Cook County.

What medical group is Dr. Carlos Galvez part of?

Dr. Galvez is linked to University of Illinois Physicians Group (UIPG). Dmand AI links Dr. Galvez to 1 more medical group.

Does Dr. Carlos Galvez accept Medicare?

Yes. CMS data shows Dr. Galvez billed Medicare for 262 services in 2024, and Dr. Galvez accepts Medicare assignment.

Does Dr. Carlos Galvez offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Galvez as offering telehealth services.

What is Dr. Carlos Galvez's MIPS score?

Dr. Galvez's MIPS final score for performance year 2024 is 95 out of 100, reported as part of a group.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Carlos Galvez see?

CMS counts 74 Medicare patients who saw Dr. Galvez in 2024, with an average age of 67.

What services does Dr. Carlos Galvez bill to Medicare?

In 2024, Dr. Galvez's most billed Medicare services were office visit, established patient (99215), medicare service (G2211) and office visit, established patient (99214).

Where did Dr. Carlos Galvez go to medical school?

Dr. Galvez graduated from University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) in 2016.

What drugs does Dr. Carlos Galvez prescribe most?

In 2024 Medicare Part D data, Dr. Galvez's most prescribed drugs by claims were Prednisone, Acyclovir and Sulfamethoxazole-Trimethoprim.

Has Dr. Carlos Galvez received payments from drug or device companies?

CMS Open Payments shows $11,679 in general payments to Dr. Galvez from 7 companies from 2023 to 2025. The largest total came from Kite Pharma, Inc.

How long has Dr. Carlos Galvez been practicing?

Dr. Galvez graduated from medical school in 2016, 10 years ago.

Does Dr. Carlos Galvez do research?

Dmand AI links 15 publications to Dr. Galvez, published from 2017 to 2025.

Who does Dr. Carlos Galvez publish with?

Dr. Galvez's most frequent co-authors are Leo I. Gordon, MD (3 shared papers), Reem Md Karmali, MD (3 shared papers) and Jane N. Winter, MD (3 shared papers).

Selling to hematology and oncology practices?

See hematologists and oncologists in Illinois by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)